InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Tuesday, 08/14/2012 9:08:00 PM

Tuesday, August 14, 2012 9:08:00 PM

Post# of 345980
Here we have the 3 analysts from wedbush (biotechnology) that may initiate coverage on PPHM after Wedbush analysts are able to get up and personal...

1) Chris Marai
2) Greg Wade
3) Dr. David Nierengarten

My guess would be Dr. David N. : ) and looking forwward for the price target that would be associated with PPHM

----------------------------------------------
Below is from the WedBush conference today for "Sarepta" but posted just to point out the 3 biotechnology team from Wedbush...

"Great. Good afternoon. Hi, guys, my name is Chris Marai, I work here as an analyst on the Wedbush biotechnology team with Greg Wade and Dr. David Nierengarten. It’s my pleasure to introduce Chris Garabedian of Sarepta Pharmaceuticals. Chris?"

site reference:

http://www.thestreet.com/story/11664085/1/sarepta-therapeutics-ceo-presents-at-wedbush-pacgrow-life-sciences-management-access-conference-transcript.html

--------------------------------------------

Why would Peregrine be showing up at these meet and greets ... IF they didn't have the goods... just my opinion ... lets just hope they impress the investors and build this institutional ownership up and up.... still say we'll be atleast 33% Inst. Ownership by next cc
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News